Ashford Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $292K | Sell |
317
-19
| -6% | -$19.3K | 0.04% | 92 |
|
|
2025
Q4 | $361K | Hold |
336
| – | – | 0.04% | 94 |
|
|
2025
Q3 | $256K | Hold |
336
| – | – | 0.03% | 105 |
|
|
2025
Q2 | $262K | Sell |
336
-17
| -5% | -$13.2K | 0.03% | 95 |
|
|
2025
Q1 | $292K | Sell |
353
-12
| -3% | -$9.98K | 0.04% | 93 |
|
|
2024
Q4 | $282K | Sell |
365
-22
| -6% | -$18.2K | 0.03% | 95 |
|
|
2024
Q3 | $343K | Sell |
387
-40
| -9% | -$36K | 0.04% | 93 |
|
|
2024
Q2 | $387K | Sell |
427
-81
| -16% | -$64.8K | 0.05% | 88 |
|
|
2024
Q1 | $395K | Sell |
508
-68
| -12% | -$48.4K | 0.05% | 83 |
|
|
2023
Q4 | $336K | Sell |
576
-50
| -8% | -$29.2K | 0.05% | 89 |
|
|
2023
Q3 | $336K | Hold |
626
| – | – | 0.05% | 85 |
|
|
2023
Q2 | $294K | Sell |
626
-71
| -10% | -$29.8K | 0.04% | 82 |
|
|
2023
Q1 | $239K | Sell |
697
-38
| -5% | -$12.8K | 0.04% | 85 |
|
|
2022
Q4 | $269K | Hold |
735
| – | – | 0.04% | 83 |
|
|
2022
Q3 | $238K | Sell |
735
-108
| -13% | -$34.2K | 0.04% | 89 |
|
|
2022
Q2 | $273K | Hold |
843
| – | – | 0.04% | 87 |
|
|
2022
Q1 | $241K | Hold |
843
| – | – | 0.03% | 95 |
|
|
2021
Q4 | $233K | Buy |
+843
| New | +$214K | 0.02% | 100 |
|
|
2020
Q3 | – | Sell |
-1,366
| Closed | -$224K | – | 100 |
|
|
2020
Q2 | $224K | Buy |
+1,366
| New | +$210K | 0.03% | 94 |
|
|
2020
Q1 | – | Sell |
-1,662
| Closed | -$218K | – | 94 |
|
|
2019
Q4 | $218K | Sell |
1,662
-144
| -8% | -$16.7K | 0.03% | 87 |
|
|
2019
Q3 | $202K | Sell |
1,806
-699
| -28% | -$77.8K | 0.03% | 96 |
|
|
2019
Q2 | $278K | Hold |
2,505
| – | – | 0.04% | 91 |
|
|
2019
Q1 | $325K | Hold |
2,505
| – | – | 0.05% | 86 |
|
|
2018
Q4 | $290K | Hold |
2,505
| – | – | 0.05% | 105 |
|
|
2018
Q3 | $269K | Hold |
2,505
| – | – | 0.03% | 110 |
|
|
2018
Q2 | $214K | Buy |
+2,505
| New | +$206K | 0.03% | 105 |
|
|
2018
Q1 | – | Sell |
-2,505
| Closed | -$212K | – | 106 |
|
|
2017
Q4 | $212K | Hold |
2,505
| – | – | 0.03% | 100 |
|
|
2017
Q3 | $214K | Hold |
2,505
| – | – | 0.03% | 107 |
|
|
2017
Q2 | $206K | Hold |
2,505
| – | – | 0.04% | 103 |
|
|
2017
Q1 | $211K | Buy |
+2,505
| New | +$201K | 0.04% | 104 |
|
|
2016
Q4 | – | Sell |
-2,505
| Closed | -$201K | – | 107 |
|
|
2016
Q3 | $201K | Buy |
+2,505
| New | +$201K | 0.04% | 106 |
|
|
2016
Q1 | – | Sell |
-2,505
| Closed | -$211K | – | 105 |
|
|
2015
Q4 | $211K | Buy |
+2,505
| New | +$208K | 0.05% | 105 |
|
Other funds holding LLY
VCM
VPM
Ashford Capital Management's LLY Position: Q1 2026 in Review
Ashford Capital Management reduced its Eli Lilly (LLY) stake by 5.7% in Q1 2026, selling an estimated $19.3K and leaving 317 shares worth $292K. The position accounts for 0.04% of the portfolio, ranked #92.
Ashford Capital Management first reported a position in LLY in Q4 2015 and has held it in 32 quarters since. The position peaked at $395K in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Ashford Capital Management held 317 shares of Eli Lilly worth $292K as of Q1 2026.
- Ashford Capital Management sold 19 Eli Lilly shares in Q1 2026, an estimated $19.3K.
- Eli Lilly made up 0.04% of Ashford Capital Management's portfolio in Q1 2026, its #92 holding.
- Ashford Capital Management first reported a position in Eli Lilly in Q4 2015 and has held it in 32 quarters since.
- Ashford Capital Management's Eli Lilly position peaked at $395K in Q1 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Ashford Capital Management's 13F filing for Q1 2026, filed 15 May 2026.